JAG1 promotes migration, invasion, and adhesion of triple-negative breast cancer cells by promoting angiogenesis.
10.12122/j.issn.1673-4254.2022.07.21
- Author:
Jun Ping LIU
1
;
Yu Tong SHI
1
;
Min Min WU
1
;
Meng Qi XU
1
;
Feng Mei ZHANG
1
;
Zhi Qiang HE
1
;
Min TANG
1
Author Information
1. Key Laboratory of Clinical Laboratory and Diagnostics of Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.
- Publication Type:Journal Article
- Keywords:
JAG1;
angiogenesis;
triple-negative breast cancer;
tumor microenvironment;
vascular endothelial cell growth factor-A
- MeSH:
Animals;
Cell Line, Tumor;
Cell Movement;
Cell Proliferation;
Culture Media, Conditioned;
Female;
Human Umbilical Vein Endothelial Cells/metabolism*;
Humans;
Jagged-1 Protein/metabolism*;
Mice;
Mice, Nude;
Neovascularization, Pathologic/metabolism*;
Platelet Aggregation Inhibitors;
Sincalide/metabolism*;
Triple Negative Breast Neoplasms/metabolism*;
Tumor Microenvironment
- From:
Journal of Southern Medical University
2022;42(7):1100-1108
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the effect of JAG1 on the malignant phenotype of triple-negative breast cancer (TNBC) and its role in angiogenesis in breast cancer microenvironment.
METHODS:The expressions of Notch molecules were detected in human TNBC 231 and 231B cells using RT-qPCR. Five female nude mice were inoculated with 231 cells and another 5 with 231B cells into the mammary fat pads, and 4-6 weeks later, the tumors were collected for immunohistochemical and immunofluorescence tests. 231 cells and 231B cells were treated with recombinant JAG (rJAG) protein and DAPT, respectively, and changes in their malignant phenotypes were assessed using CCK-8 assay, Hoechst 33258 staining, wound healing assay, Transwell chamber assay and endothelial cell adhesion assay. Western blotting was used to detect the changes in the expressions of proteins related with the malignant phenotypes of 231 and 231B cells. The effects of conditioned medium (CM) derived from untreated 231 and 231 B cells, rJAG1-treated 231 cells and DAPT-treated 231B cells on proliferation and tube formation ability of cultured human umbilical vein endothelial cells (HUVECs) were evaluated using CCK-8 assay and tube-forming assay.
RESULTS:The expression of JAG1 was higher in 231B cells than in 231 cells (P < 0.05). Tumor 231B showed higher expression of VEGFA and CD31. Compared with 231-Blank group, the migration, invasion and adhesion of 231 cells in 231-rJAG1 were significantly enhanced (P < 0.05). Protein levels of Twist1 and Snail increased (P < 0.01), anti-apoptotic protein Bcl-2 increased (P < 0.05), while DAPT inhibited the related phenomena and indicators of 231B. The 231-rJAG1-CM increased the cell number and tubule number of HUVEC (P < 0.05).
CONCLUSION:JAG1 may affect the malignant phenotype of TNBC and promote angiogenesis in the tumor microenvironment.
